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Recent outbreaks of nephrolithiasis and acute kidney injury
among children in China have been linked to ingestion of
milk-based infant formula contaminated with melamine.
These cases provide evidence in humans for the
nephrotoxicity of melamine, which previously had been
described only in animals. The consequences of this outbreak
are already severe and will likely continue to worsen. Herein
we summarize the global impact of the melamine milk
contamination, the reemergence of melamine-tainted animal
feed, and potential mechanisms of melamine nephrotoxicity.
Large-scale epidemiologic studies are necessary to further
characterize this disease and to assess its potential long-term
sequelae. This epidemic of environmental kidney disease
highlights the morbidity associated with adulterated food
products available in today’s global marketplace and reminds
us of the unique vulnerability of the kidney to environmental
insults. Melamine is the latest in a growing list of diverse
potentially toxic compounds about which nephrologists and
other health-care providers responsible for the diagnosis and
management of kidney disease must now be aware.
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GLOBAL IMPACT OF THE MILK CONTAMINATION IN CHINA
Melamine contamination of foodstuffs produced in China
is an international public health crisis, and the full
repercussions of this scandal may not be known for many
years. A recent report by the World Health Organization
(WHO) estimated that 51,900 children in the People’s
Republic of China have been affected and six deaths have
resulted due to melamine contamination.1 After initial
reports of nephrolithiasis among Chinese infants who drank
milk-based formula surfaced in the summer of 2008, a
systematic search by the Chinese Administration of Quality
Supervision, Inspection, and Quarantine (AQSIQ) revealed
22 commercial brands of milk powder (69 batches out of 491
tested) with detectable levels of melamine.2 Thirteen of
the batches contained 42.5 parts per million (p.p.m.)
(2.5 mg/kg), the level of melamine above which the
United States Food and Drug Agency (USFDA) had
conservatively concluded would exceed the tolerable daily
intake of 0.063 mg/kg of body weight/day in humans.3
The culprit powder with the highest melamine concentration,
produced by the Shijiazhuang-based San Lu company,
the largest national distributor and exporter of milk
powder, contained samples with 2563 p.p.m. of melamine,
more than 1000-fold higher than the USFDA tolerable daily
intake.2 As of 12 September 2008, 66 of 175 infant formula
manufacturers across China had halted production, and the
remaining 109 manufacturers were undergoing investigation.
This controversy required reaction from the highest levels of
the Chinese government. The chief of the AQSIQ, Li
Changjang, resigned, and Premier Wen Jiabao recently
apologized publicly and promised reform of current safety
regulations.4
Children outside of mainland China in Taiwan, Hong
Kong, and Macau have also been affected.1 Reports of
detectable melamine in foodstuffs from around the globe
continue to document the widespread nature of this
epidemic. Sixty-eight countries (see Figure 1) have already
taken decisive action to limit the dissemination of con-
taminated products,4 which include Chinese-made milk-
based infant formula and milk-based products, such as
cookies and chocolates (see Table 1). Other nations are now
monitoring the incidence of nephrolithiasis as a surrogate for
melamine intoxication in their respective populations.5
m i n i r e v i e w http://www.kidney-international.org
& 2009 International Society of Nephrology
Received 4 December 2008; accepted 9 December 2008; published
online 11 February 2009
Correspondence: Vivek Bhalla, Division of Nephrology, Department of
Medicine, 780 Welch Road, Suite 106, Stanford University, Palo Alto,
California 94304, USA. E-mail: vbhalla@stanford.edu
774 Kidney International (2009) 75, 774–779
Several international agencies including the World Health
Organization (WHO), the Food and Agriculture Organiza-
tion (FAO), the European Food Safety Association (EFSA),
and the International Food Safety Authorities Network
(INFOSAN) are working together to characterize and control
this outbreak.1 The USFDA has twice amended its assessment
of melamine toxicity for infants, and concluded that only
foods with less than 1 p.p.m. of melamine are safe for
infants.3 The USFDA has also announced the establishment
of an office in Beijing, China to oversee exports shipped to
the United States.3
ADDITIONAL MELAMINE CONTAMINATION IN ANIMAL FEED
Two international incidents in 2004 and 2007 showed that
pet food containing a wheat gluten exported from China was
responsible for kidney failure and death in domesticated cats
and dogs in the United States and Europe.3 Pet food scraps in
the United States from the 2007 outbreak revealed similar
levels of melamine as the infant formulas recently produced
in China, ranging from 9.4 to 1952 p.p.m.3 as well as another
compound, cyanuric acid.3 The 2004 pet food outbreak is
presumed to have been due to melamine because autopsy
reports from 2004 are comparable with those of animals that
died in 2007. In October 2008, hundreds of raccoon dogs in
China died from kidney failure after the ingestion of
melamine-contaminated animal feed. Reports from Hong
Kong and other nations state that chicken eggs and fish (fit
for human consumption) recently imported from China
contain melamine,4 providing circumstantial evidence that
the food supply is now contaminated and demonstrating that
this epidemic is pervasive. The WHO has criticized the
Chinese government for not effectively eliminating melamine
from the animal feed supply despite a ban imposed in June
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Figure 1 | Global impact of the outbreak of melamine nephrotoxicity in humans. World map with countries where cases of melamine
nephrotoxicity have been reported (red); countries initially warned by the Chinese government after the first official reports of acute kidney
injury (AKI) in September 2008; countries since initial report that have taken action to ban or recall various imported goods suspected to
contain melamine.2,4
Table 1 | FDA’s warnings/advisories
Fresh and Crispy Jacobina Biscuits
Koala’s March Cre`me filled Cookies
YILI Brand Sour Milk Drink
YILI Brand Pure Milk Drink
Blue Cat Flavoured Drinks
White Rabbit Candies
Mr. Brown Mandheling Blend Instant Coffee (3-in-1)
Mr. Brown Arabica Instant Coffee (3-in-1)
Mr. Brown Blue Mountain Blend Instant Coffee (3-in-1)
Mr. Brown Caramel Macchiato Instant Coffee (3-in-1)
Mr. Brown French Vanilla Instant Coffee (3-in-1)
Mr. Brown Mandheling Blend Instant Coffee (2-in-1)
Mr. Brown Milk Tea (3-in-1)
Infant formula manufactured in China
As of 3 December 2008, the US Food and Drug Administration (FDA) advised
consumers not to consume these products because of possible melamine
contamination.3
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2007.4 Milk-based products, animals, and animal by-
products are all believed to be potential sources of melamine
exposure for humans.
MELAMINE, CYANURIC ACID, AND THE KIDNEY
Melamine is a synthetic chemical used in a variety of inedible
commercial products including cleaning supplies, dry erase
boards, and other plastics.4 Owing to its high non-protein
nitrogen content, melamine can be added to milk or animal
feed to falsely elevate the apparent protein content of these
products. In the case of milk-based infant formula, the
inclusion of melamine to boost the apparent protein content
allowed manufacturers to dilute the milk yet still pass
product quality control tests. Presumably, a similar rationale
(false documentation of high protein content) led to the pet
food outbreaks from melamine-contaminated feed in 2004
and 2007.1 The notion that farmers could taint such a
commodity is certainly not new, nor limited to a single
country. Adulterated milk from dairy farms in New York state
in the 1850s, ‘swill milk’, led to widespread illness and
eventually to more stringent regulation of the industry in the
United States.4
The mechanism of melamine nephrotoxicity is still
unknown, but clues are available from animal studies.
Melamine is rapidly excreted in the urine (90% of the
administered dose in 24 h),6 but melamine can precipitate in
distal renal tubules.7,8 Histopathologic specimens from
affected cats and dogs from the 2004 and 2007 outbreaks
show characteristic intratubular green radial crystals (see
Figure 2) and crystalluria.7,8 The morphology and histo-
chemical staining pattern is distinct from calcium oxalate or
calcium phosphate crystals.7 Some affected animals suffered
from acute kidney injury (AKI), whereas others developed
chronic kidney disease (CKD). Melamine-associated AKI in
animals was characterized by necrosis of distal tubular cells
and mild inflammation (see Figure 2, left). Chronic toxicity
showed larger crystals, interstitial inflammation, and fibrosis
(see Figure 2, right). Large crystals in the renal papilla were
also described.7 Similar lesions were found on autopsy from
other species with experimentally induced AKI after exposure
to melamine and cyanuric acid.9 AKI in these animals is
presumed to be due, at least in part, to increased intrarenal
pressure developing after intratubular obstruction from crystal
deposition and distal tubular necrosis. Autopsy specimens from
cats and dogs with AKI also suggested that they may have had
AKI due to corticomedullary hemorrhage or inflammation.7,8
Melamine and related amine analogs have natriuretic proper-
ties in dogs at a dose of 125 mg/kg, and thus, may exacerbate
AKI by leading to pre-renal azotemia in susceptible animals or
individuals.10 The nitrogen content of melamine is unlikely to
artificially increase the blood urea nitrogen (and thus feign
AKI) because in autopsy studies, detection of melamine in
diseased renal tissue occurred in the absence of melamine
metabolites.8
Toxicity studies in male rats show a low toxicity profile
(defined as urolithiasis) and a high LD50 of 3161 mg/kg body
weight.3 If extrapolated to cats and dogs, one would predict
that the amount of melamine measured in the contaminated
pet food would not result in crystal deposition. In rats,
chronic melamine exposure did not result in histologic
damage to renal tubules.10 Similarly, the LD50 of cyanuric
acid in rats is low (45000 mg/kg).11 Interestingly, when
tested directly, neither melamine nor cyanuric acid alone
causes nephrolithiasis or AKI in cats, pigs, or fish, but both
are necessary and sufficient to cause melamine-cyanurate co-
crystallization both in vivo and in vitro.8,9
Cyanuric acid, melamine’s ‘partner-in-crime,’ is a white,
odorless solid, which has been used for many years as a
chlorine-stabilizing agent in swimming pools.11 Cyanuric
acid forms an insoluble lattice structure when mixed with
melamine at pH 5.8. In fact, it is this reaction which provides
a standard gravimetric and turbidimetric method to measure
the level of cyanuric acid in chlorinated swimming pool
water.11 This feature may also explain why intratubular
crystal deposition is seen in the distal nephron in animals
with this disease, unlike in oxalosis where crystal deposition
is predominantly in the proximal nephron. Therefore, low
urinary pH may be a risk factor for crystal deposition and
AKI in humans. A compound exposure to melamine and
cyanuric acid may determine which patients are susceptible
to nephrolithiasis and possibly to AKI. Levels of cyanuric
acid in foods have not been systematically and rigorously
tested. Thus far only insignificant amounts of cyanuric acid
have been detected in stones from affected infants.1
Interestingly, high levels of uric acid were found in stones
from some infants with melamine nephrotoxicity. Until
published data emerge from individuals affected with acute
melamine nephrotoxicity, the precise mechanisms underlying
this form of kidney injury will be incompletely characterized
(Figure 3).
Figure 2 | Representative histopathologic lesions of melamine
nephrotoxicity in animals. (Left) Hematoxylin and eosin (H&E)
stain of kidney tissue from a cat with melamine-associated acute
kidney injury. Dilated distal tubule contains fragmented or
globular dense green melamine-cyanuric acid crystals (long
arrows). Note attenuation of the lining epithelium, wide
separation of nuclei (short arrow), and mitotic figure (arrowhead)
indicative of tubular epithelial necrosis and regeneration.
Bar¼ 45 mM. (Right) H&E stain of kidney tissue from a dog with
melamine-associated chronic kidney disease. Large aggregates of
characteristic crystals distend a distal tubule. Tubular epithelial
cells (short arrow) partially cover the crystals, with plasma cells
(long arrow) in the fibrotic interstitium. Bar¼ 50 mM. Adapted with
permission from Brown et al., 2007.7
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No epidemiologic data on the clinical characteristics of the
current outbreak have been published in peer-reviewed
journals, but the Chinese Ministry of Health has provided a
working definition of melamine nephrotoxicity.1 A case is
defined as an infant with nephrolithiasis or other kidney
problems after having consumed powdered infant formula
produced in China before 6 August 2008, where other
potential causes of nephrolithiasis have been excluded.
Although the working definition of melamine nephrotoxicity
does not require demonstration of intraparenchymal deposi-
tion of melamine or evidence of cyanuric acid exposure,
studies in other mammals suggest that the working definition
is reasonable. Diagnostic criteria include bilateral calculi in
the pelvis and/or ureters leading to complete urinary tract
obstruction, as assessed by ultrasound (melamine-related
stones are radiolucent). The treatment advocated by the
Chinese Ministry of Health is hydration, urinary alkaniza-
tion, conservative pain management, renal replacement
therapy, and surgical treatment if necessary.1
ENDURING EFFECTS OF THIS EPIDEMIC
This outbreak should place all nephrologists on alert for the
foreseeable future. The unknown duration of milk powder
contamination and the reemergence of melamine in animal
feed signify that melamine intoxication is most likely to
increase rather than decrease as more rigorous testing is
performed, and the contamination is deep within the food
chain, making a recall unlikely to be successful in eradicating
all potential exposures to humans.
Recent epidemiologic data suggest that stone formation is
an independent risk factor for CKD later in life (Rule A,
Bergstralh E, Melton L, et al., ASN abstract, 2008, in press).
Melamine nephrotoxicity in humans was first reported in
September 2008, and further assessments may uncover a
longer-term contribution to kidney disease than the severest
cases in children currently being reported. Furthermore,
children may be more susceptible from contaminated milk
(due to increased dosing), but adults may also have been
affected through ingestion of milk-based goods and/or
animal by-products. Without a systematic survey of ne-
phrolithiasis and AKI cases over the past several years, it is
impossible to know for certain. Cases of nephrolithiasis
without clinically overt AKI may lead to CKD, similar to
autopsy findings in dogs that fell ill after chronic ingestion of
adulterated pet food in 20077 (Figure 3). Although the
estimates are that 51,900 children were affected in this latest
event in China, this may be only the tip of the iceberg.
It is possible that there are an even larger number of infants
with subclinical melamine toxicity, where they remain
asymptomatic with life sustaining renal function for now,
but with their potential for future renal growth severely
constrained. This may only become clinically apparent when
they ‘outgrow’ their kidney function at some time in the
future.
Lastly, several recent studies in both pediatric and adult
populations have confirmed that episodes of AKI can
contribute not only to mortality and morbidity but also to
progression of CKD. Some investigators have suggested that
10% or more of cases of end-stage renal disease (ESRD)
incident in the United States are precipitated by AKI.12 It is
too early to tell whether the current outbreak of melamine
nephrotoxicity will have long-term implications on pediatric
or adult CKD or ESRD in China or other countries. Close
follow-up of children with acute lead exposure in the early
twentieth century in Queensland, Australia showed a
markedly increased risk of CKD and hypertension 30–40
years later.13 Thus, it is sobering to think what effect this
entity will have on the practice of nephrology, but it is certain
to linger long after the headlines of a milk scandal in China
have been forgotten. An expert panel sponsored by the WHO,
FAO, and Health Canada recommended long-term follow-up
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Figure 3 | Possible mechanisms of melamine nephrotoxicity.
Melamine is the principal culprit in this disease, but several studies
in animals and humans suggest several susceptibility factors (see
text for details). Biopsy specimens from infants with this disease
have not been reported, but studies in animals have reported
several different pathologic sequelae. Melamine nephrotoxicity is
characterized by nephrolithiasis, acute kidney injury (AKI), or both.
Whether chronic kidney disease (due to repeated cases of
nephrolithiasis or due to AKI) occurs in humans is unknown.
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of infants with melamine nephrotoxicity to address some of
these concerns.1
ENVIRONMENTAL EXPOSURES AND KIDNEY DISEASE
This Chinese milk controversy and emerging cases of kidney
disease in infants is another reminder of how nephrology and
the environment are intertwined. Many environmental
and/or occupational kidney diseases have been described
since the industrial revolution of the nineteenth century.
Various toxins have been associated with AKI, CKD, and
ESRD, whereas others have caused non-renal complications
in persons with pre-existing kidney disease. Similar to
melamine nephrotoxicity, most of these diseases have a
known etiologic agent and yet, despite years of national and
international safety regulations, are still with us today.
As organs responsible for much of the body’s waste
management, with extensive exposure to blood-borne toxins,
the kidneys often bear the burden of clearing the bloodstream
of materials to which humans are parenterally or enterally
exposed. The recent recognition of acute phosphate nephro-
pathy following exposure to phosphate-containing bowel
preparations is a good example of this vulnerability.14
Just as melamine has emerged in the past few months, in
an era of free trade and globalization, new toxins will
certainly surface, and tools designed to rapidly identify cases
and their etiology will be necessary. The prospect of earlier
detection of AKI with novel biomarkers has gained traction
over the past several years. Newer biomarkers could facilitate
diagnosis of AKI in hospitalized patients and may also
identify potentially nephrotoxic pharmaceuticals or food
additives in preclinical studies.15
Several CKDs have been ascribed to occupational or
environmental exposures. Occupational kidney diseases,
including chronic lead nephropathy, cadmium nephrotoxi-
city, and nephropathy due to other heavy metals or solvents,
have been described for decades,13 but lead, for example, is
still encountered today as a progression factor for CKD.16
Analgesic nephropathy is caused by well-recognized, over-
the-counter ‘toxins,’ particularly in Europe and Australia.17
Aristolochic acid, which has been used as a component of
weight loss regimens and is probably the etiologic agent of
endemic Balkan nephropathy,18 is an example of a toxin that
was used therapeutically and/or was present in the environ-
ment and caused kidney disease for many years before being
identified as such.
Several other toxic exposures have affected patients with
pre-existing kidney disease by virtue of poor solute clearance.
Itai-itai byo or ‘ouch-ouch’ disease in post-World War II
Japan caused by cadmium contamination of rice fields
downstream of metal mining operations – caused Fanconi
syndrome and osteomalacia in many individuals, but those
with decreased glomerular filtration rate were among the
most severely affected.13 Infants with CKD whose organ
systems are still developing may be most sensitive and
therefore act as ‘sentinel canaries’ for the detection of
environmental toxins, where the effects may be amplified
compared with those effects in adults. In pediatric patients
with CKD, aluminum binders were often prescribed at the
same time as citrate-containing base supplements to treat
metabolic acidosis in CKD. This combination markedly
increased the absorption of aluminum by the gastrointestinal
tract further aggravating the neurotoxic effects of aluminum
in the developing brain.19 It is an important lesson that this
interaction had been recognized in the early 1980s, but these
therapies continued to be used by physicians for many years
after. More recent concerns have centered on the use of
gadolinium-chelating agents for contrast enhancement on
magnetic resonance imaging. While epidemiologists even-
tually identified gadolinium as the culprit etiologic agent of
nephrogenic systemic fibrosis, the insidious onset and
relatively low incidence rate delayed recognition of the
association for many years.20
These examples highlight the challenges facing nephrol-
ogists and other health providers in establishing links
between hazardous environmental exposures, the develop-
ment or progression of kidney disease, and/or complications
of CKD. Particularly in view of the high prevalence of CKD,
with a large fraction of the disease burden unexplained by
known risk factors, we should probably adopt a high index of
suspicion for environmental and/or occupational exposures
as potential contributing causes.
CONCLUSION
Melamine can crystallize in distal renal tubules and most
likely explains the series of reported cases of nephrolithiasis
and AKI in East Asia. Actions taken by several national and
international oversight agencies probably prevented the
spread of melamine-tainted food products, and may have
already prevented tens of thousands of cases of AKI.
However, it is likely that additional melamine-contaminated
food products remain on store shelves and home cupboards,
poised for consumption, and other contaminated
products exist within the global food supply. The recent
move by the USFDA to open an office in Beijing to help
monitor the safety of goods exported to the United States
may help, but will not prevent similar occurrences related to
products in other countries whose products are consumed in
the United States and overseas. More comprehensive public
health prevention programs focused on nephrolithiasis and
acute and chronic kidney diseases may help to identify potent
environmental toxins before they lead to unnecessary deaths
or to a global epidemic.
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